Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sandra Gallina
Health Security Beyond Defense: Building Resilience Against Future Health and Security Threats
How Defense, Diplomacy, and Innovation Can Build More Resilient Societies Time 14:00-15:30 CEST 12:00-13:30 UTC Russia’s war on Ukraine and a fracturing geopolitical order have made clear that robust defence is non-negotiable but military strength alone cannot deliver lasting security.
La sfida della copertura sanitaria universale che aspetta l'Ue
L’Universal health coverage (Uhc) è uno dei pilastri fondamentali della strategia globale dell’Ue in materia di salute, lanciata dalla Commissione europea con lo scopo di perseguire una società più sana, resiliente ed equa a livello globale.
Breaking barriers: The European Commission’s commitment to tackling rare diseases
Rare diseases only affect a small percentage of the population, but collectively they impact millions of people. Up to 36 million European Union citizens are suffering from a rare disease today. These patients often face frustration, discomfort and fear as they struggle to find out what is wrong or how to deal with it. When it comes to tackling rare diseases, the added value of EU action is undisputable.
Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global crisis has revealed to us all the need for collective action to protect and enhance the well-being of our Union’s citizens. While the pandemic was not the initial catalyst, it served as a focal point that strengthened our determination to continue the ongoing efforts to improve our Union’s health and pharmaceutical industry.
EU-Kommission spielt Antibiotika-Mangel herunter
Sprachen: English | Français Der derzeitige Mangel an Antibiotika sei für Europa ein „großes Alarmsignal“, erfordere aber keine besonderen Maßnahmen, da den Mitgliedstaaten Alternativen zur Verfügung stünden, erklärte eine hochrangige Beamte der EU-Kommission. Engpässe bei bestimmten Arzneimitteln – insbesondere bei Antibiotika für die Pädiatrie – bereiten europäischen Regierungen und ihren Aufsichtsbehörden Kopfzerbrechen.
Patientenvertreter fordern mehr EU-Gelder für Forschung zu Long Covid
Sprachen: English | Français Patientenvertreter:innen haben von der EU gefordert, mehr Mittel für die Erforschung der Auswirkungen von Long Covid bereitzustellen. 17 Millionen Menschen sind EU-weit derzeit betroffen. „Ohne Behandlung werden die Patient:innen niemals geheilt werden“, warnte die Long-Covid-Patientin Anne Li von der Patientenvereinigung Long COVID Europe auf einer von der Europäischen Kommission organisierten Konferenz am Dienstag (13. Dezember). Einem am 13.
Gesundheitspolitik: Brüssel und EU-Länder müssen „Doppelarbeit vermeiden“
Bei der angekündigten EU-Strategie für globale Gesundheit müssten Brüssel und die Mitgliedstaaten stärker zusammenarbeiten, erklärt die „Nummer 2“ der EU-Kommission für Gesundheitspolitik, Sandra Gallina, im Interview mit EURACTIV. Sandra Gallina ist Generaldirektorin in der Generaldirektion Gesundheit der Europäischen Kommission.
L’addio a Mauro Petriccione, direttore generale della Commissione europea
Nato a Taranto, aveva studiato a Bari e a Londra ed era entrato alla Commissione a trent’anni. Nel 2018 l’incarico più importante: direttore generale della Dg Clima per la preparazione del green deal europeo Un senso di sgomento e di smarrimento ci ha colpiti, all’improvviso, la sera del 22 agosto 2022 quando ci è giunta la terribile notizia che Mauro Petriccione, uno dei direttori generali più preparati ed esperti della Commissione Europea, ci aveva lasciato.
The European Strategy for Universities: a catalyst for national reforms and investments?
The European Commission’s new higher education package is welcomed by Europe’s universities. It provides us with a positive, supportive narrative that respects our role in driving the transition to a more sustainable world. The Package also proposes initiatives that will facilitate cooperation between universities in Europe and beyond. Its success will be measured by concrete changes for universities and their communities on the ground.
Orphan medicinal products: onwards and upwards
The Orphan Medicinal Products (OMPs) Regulation and the Paediatric Regulation, first adopted in 2001 and 2006 respectively, partly overlap. This is because many diseases that affect only children are rare, and rare diseases often affect children. Both regulations have introduced obligations, incentives and rewards to address the market failure to provide medicinal products for these patients.
Tackling rare diseases through enhanced coordination
Though the name suggests otherwise, rare diseases affect far too many Europeans, with up to 36 million people within the EU suffering from such diseases. Ahead of this year’s Rare Diseases Day, I wish to reaffirm the EU’s unwavering commitment to tackling these illnesses, while also improving the lives of those that they touch. READ MORE: This article is published as part of our special supplement looking at how Europe can come together to find solutions for people suffering from a rare disease.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sandra
Contact Sandra, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack